IFNG and cancer: The PDL1-Dox treatment has multimodal anticancer effects including tumor acidic pH responsive drug release, apoptosis mediated cancer cell death, targetability of PDL1 receptor and tumor 3D-spheroid disruption, and upmodulating of tumor suppressing IFN-γ mediated immune cell activation.